Ipsen – Half year statement – 2024 12 31
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF
Boulogne-Billancourt (France), January 7th, 2025 – Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of December 31, 2024, the following resources were included to the dedicated liquidity account:
- 24,701 shares
- €2,635,980.25
It is reminded that as of the date of the implementation of the agreement, the following resources were allocated to the liquidity account:
- 12,751 shares
- €3,137,934.80
Between July 1st, 2024 and December 31st, 2024 have been executed:
- 2,936 purchase transactions
- 2,346 sell transactions
Under the same period, the volumes traded represented:
- 311,792 shares and €33,997,824.80 to the purchase
- 321,682 shares and €35,215,771.10 to the sel
Attachment

Ipsen – Half year statement – 2024 12 31
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF
Boulogne-Billancourt (France), January 7th, 2025 – Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of December 31, 2024, the following resources were included to the dedicated liquidity account:
- 24,701 shares
- €2,635,980.25
It is reminded that as of the date of the implementation of the agreement, the following resources were allocated to the liquidity account:
- 12,751 shares
- €3,137,934.80
Between July 1st, 2024 and December 31st, 2024 have been executed:
- 2,936 purchase transactions
- 2,346 sell transactions
Under the same period, the volumes traded represented:
- 311,792 shares and €33,997,824.80 to the purchase
- 321,682 shares and €35,215,771.10 to the sel
Attachment

Related stories
Dans la biopharma, la créativité est au cœur des partenariats, de la structure à l’exécution
Journée mondiale de l’environnement : agir là où cela compte le plus
Relever les défis les plus exigeants : l’engagement d’Ipsen au service des besoins médicaux non satisfaits
Related Press Releases
Ipsen – May 2026 – Monthly information relative to the...
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen announces the launch of an Employee Shareholding Plan
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – April 2026- Monthly information relative to the total...
Ipsen initiates a new share buy-back program
Ipsen S.A. – Evolution of the composition of the Board...
Annual General Meeting of Ipsen S.A. held on 13 May...
Ojemda® approved in the European Union as the first targeted...